Suggested Searches

photo of James M Winkley, II
859-260-3330

James M Winkley, II, MD

Neurology
Gender: Male
4.7 of 5 (408 Ratings)
Accepting New Patients
Virtual Visits

Clinical Focus

Multiple Sclerosis

Practice Locations

A:
Baptist Health Medical Group Neurology
610 East Brannon Road, Suite 201
Nicholasville, KY 40356
859-260-3330 859-260-3331

Education

Medical School

Indiana University School of Medicine

Residency

University of Iowa Hospitals and Clinics

Internship

Indiana University School of Medicine

Fellowship

Wake Forest University School of Medicine GME

Hospital Affiliations

  • Baptist Health Corbin
  • Baptist Health Lexington

Philosophy of Care

Baptist Health Medical Group is a comprehensive, multispecialty network of physicians and advanced practice clinicians. Our providers are committed to providing compassionate, patient-centered care and strive to treat our patients the way we would want to be treated, every time, at every Baptist Health location.

Reviews

Patient Experience Ratings

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Overall Rating
4.7 out of 5 (408 Ratings)
Review Categories
Patient Comments

Research

  • Generalized Myasthenia Gravis

    ALXN1720-MG-301: A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis

    Trial Details
  • Generalized Myasthenia Gravis

    ALXN-MG-501: Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies

    Trial Details
  • Multiple Sclerosis

    Gavotte: A Phase IIIB Multicenter, Randomized, Double-Blind, Controlled study to evaluate the efficacy, safety and pharmacokinetics of a higher dose of Ocrelizumab in adults with primary progressive multiple sclerosis

    Trial Details
  • Neuromyelitis Optica Spectrum Disorder

    SPHERES NMOSD Registry: CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Trial Details
  • Relapse Remitting Multiple Sclerosis

    AGNOS: An 18-month, Open-label, Multi-Center Study to Assess the Effect of Ofatumumab 20mg SC Monthly in Treatment Naïve, Very Early Relapsing Remitting Multiple Sclerosis Patients Benchmarked Against Healthy Controls on Select Outcomes.

    Trial Details
  • Relapsing-Remitting Multiple Sclerosis

    SOSTOS: A randomized, open label, multi-center, active-comparator study to assess the efficacy, safety and tolerability of ofatumumab 20mg sc monthly versus continued current therapy

    Trial Details